Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects.
Saved in:
| Title: | Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects. |
|---|---|
| Authors: | Vizeli P; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.; Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States., Straumann I; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Duthaler U; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Varghese N; Psychiatric University Hospital, University of Basel, Basel, Switzerland.; Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland., Eckert A; Psychiatric University Hospital, University of Basel, Basel, Switzerland.; Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland., Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, United States., Risbrough V; Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States.; Center of Excellence for Stress and Mental Health, San Diego, CA, United States., Liechti ME; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Jul 13; Vol. 13, pp. 906639. Date of Electronic Publication: 2022 Jul 13 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35910354 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vizeli+P%22">Vizeli P</searchLink>; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.; Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States.<br /><searchLink fieldCode="AU" term="%22Straumann+I%22">Straumann I</searchLink>; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Duthaler+U%22">Duthaler U</searchLink>; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Varghese+N%22">Varghese N</searchLink>; Psychiatric University Hospital, University of Basel, Basel, Switzerland.; Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Eckert+A%22">Eckert A</searchLink>; Psychiatric University Hospital, University of Basel, Basel, Switzerland.; Transfaculty Research Platform Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paulus+MP%22">Paulus MP</searchLink>; Laureate Institute for Brain Research, Tulsa, OK, United States.<br /><searchLink fieldCode="AU" term="%22Risbrough+V%22">Risbrough V</searchLink>; Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States.; Center of Excellence for Stress and Mental Health, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Liechti+ME%22">Liechti ME</searchLink>; Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland.; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Jul 13; Vol. 13, pp. 906639. <i>Date of Electronic Publication: </i>2022 Jul 13 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35910354 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2022.906639 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 906639 Titles: – TitleFull: Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vizeli P – PersonEntity: Name: NameFull: Straumann I – PersonEntity: Name: NameFull: Duthaler U – PersonEntity: Name: NameFull: Varghese N – PersonEntity: Name: NameFull: Eckert A – PersonEntity: Name: NameFull: Paulus MP – PersonEntity: Name: NameFull: Risbrough V – PersonEntity: Name: NameFull: Liechti ME IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 07 Text: 2022 Jul 13 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |